phenylalanyl- cyclo(cysteinyl- tyrosyltryptophyl- lysyl- threonyl- penicillamine)threoninamide

cyclic somatostatin analog with antagonist activity at mu opioid receptors in vitro; RN given refers to (D-Phe-L-Cys-L-Tyr-D-Trp-L-Lys-L-Thr-D-Val)

Also Known As:

CTP-NH2; CTP-SRIH; Phe-cycl(Cys-Tyr-Trp-Lys-Thr-Pen)Thr-NH2; phenylalanyl-cyclo(cysteinyl-tyrosyltryptophyl-lysyl-threonyl-penicillamine)threoninamide, (L-Val)-isomer

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Ahmad, Baseer: 1 article (01/2020)
2.	Guo, Henan: 1 article (01/2020)
3.	Hou, Yanfei: 1 article (01/2020)
4.	Koci, Matthew: 1 article (01/2020)
5.	Si, Dayong: 1 article (01/2020)
6.	Wei, Xubiao: 1 article (01/2020)
7.	Zhang, Lulu: 1 article (01/2020)
8.	Zhang, Rijun: 1 article (01/2020)

Related Diseases

1.	Sepsis (Septicemia) 01/01/2020 - "In addition, the anti-inflammatory effect of CTP-NH2 was confirmed using a murine LPS-induced sepsis model. "